Shane Storey
Stock Analyst at Canaccord Genuity
(1.99)
# 3,126
Out of 4,421 analysts
339
Total ratings
46.3%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Shane Storey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $45.55 → $44.34 | $38.78 | +14.33% | 16 | May 27, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $30.00 | $14.32 | +109.50% | 53 | May 25, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $180.00 → $106.31 | $108.08 | -1.64% | 28 | May 12, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.16 → $1.35 | $0.645 | +109.30% | 28 | May 3, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $46.50 → $44.50 | $26.50 | +67.92% | 20 | May 3, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $295.00 → $120.00 | $114.29 | +5.00% | 19 | Apr 29, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.69 → $0.86 | $0.735 | +17.01% | 20 | Apr 29, 2026 | |
| ASX: ACW Actinogen Medical Limited | Maintained: Buy | $0.08 | $0.036 | +122.22% | 4 | Apr 22, 2026 | |
| ASX: OCC Orthocell Limited | Maintained: Buy | $1.33 → $1.26 | $0.77 | +63.64% | 2 | Apr 20, 2026 | |
| ASX: SOM SomnoMed Limited | Maintained: Buy | $1.00 | $0.55 | +81.82% | 22 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.43 → $5.55 | $3.22 | +72.36% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.57 | $2.03 | +26.60% | 12 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.62 → $1.58 | $1.02 | +54.90% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.85 → $2.40 | $2.19 | +9.59% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.07 → $0.06 | $0.006 | +900.00% | 22 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $350.00 | $167.61 | +108.82% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.85 → $0.80 | $0.32 | +150.00% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37.00 | $39.30 | -5.85% | 11 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.84 | $9.93 | +230.72% | 3 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.81 | $0.38 | +639.47% | 4 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.20 | $0.049 | +2,348.98% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $1.45 | +107.61% | 3 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.50 | $13.25 | +100.00% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.50 | $2.19 | +288.13% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.00 | $0.60 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5.95 → $7.40 | $2.36 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.71 → $0.55 | $0.40 | n/a | 3 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.17 → $0.06 | $0.59 | n/a | 2 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.50 → $0.55 | $0.115 | n/a | 3 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.75 | $0.013 | n/a | 1 | Jun 1, 2022 |
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Maintained: Buy
Price Target: $45.55 → $44.34
Current: $38.78
Upside: +14.33%
Telix Pharmaceuticals Limited
May 25, 2026
Maintained: Buy
Price Target: $30.00
Current: $14.32
Upside: +109.50%
CSL Limited
May 12, 2026
Downgraded: Hold
Price Target: $180.00 → $106.31
Current: $108.08
Upside: -1.64%
Aroa Biosurgery Limited
May 3, 2026
Maintained: Buy
Price Target: $1.16 → $1.35
Current: $0.645
Upside: +109.30%
ResMed Inc.
May 3, 2026
Maintained: Buy
Price Target: $46.50 → $44.50
Current: $26.50
Upside: +67.92%
Cochlear Limited
Apr 29, 2026
Maintained: Buy
Price Target: $295.00 → $120.00
Current: $114.29
Upside: +5.00%
Monash IVF Group Limited
Apr 29, 2026
Maintained: Hold
Price Target: $0.69 → $0.86
Current: $0.735
Upside: +17.01%
Actinogen Medical Limited
Apr 22, 2026
Maintained: Buy
Price Target: $0.08
Current: $0.036
Upside: +122.22%
Orthocell Limited
Apr 20, 2026
Maintained: Buy
Price Target: $1.33 → $1.26
Current: $0.77
Upside: +63.64%
SomnoMed Limited
Apr 16, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.55
Upside: +81.82%
Mar 4, 2026
Maintained: Buy
Price Target: $5.43 → $5.55
Current: $3.22
Upside: +72.36%
Mar 4, 2026
Maintained: Buy
Price Target: $3.00 → $2.57
Current: $2.03
Upside: +26.60%
Feb 23, 2026
Maintained: Buy
Price Target: $1.62 → $1.58
Current: $1.02
Upside: +54.90%
Feb 17, 2026
Downgraded: Hold
Price Target: $3.85 → $2.40
Current: $2.19
Upside: +9.59%
Feb 2, 2026
Maintained: Buy
Price Target: $0.07 → $0.06
Current: $0.006
Upside: +900.00%
Nov 18, 2025
Maintained: Buy
Price Target: $350.00
Current: $167.61
Upside: +108.82%
Nov 7, 2025
Maintained: Buy
Price Target: $0.85 → $0.80
Current: $0.32
Upside: +150.00%
Oct 3, 2025
Maintained: Hold
Price Target: $37.00
Current: $39.30
Upside: -5.85%
Sep 24, 2025
Maintained: Buy
Price Target: $32.84
Current: $9.93
Upside: +230.72%
Sep 11, 2025
Maintained: Buy
Price Target: $3.00 → $2.81
Current: $0.38
Upside: +639.47%
Sep 10, 2025
Maintained: Buy
Price Target: $1.20
Current: $0.049
Upside: +2,348.98%
Sep 2, 2025
Maintained: Buy
Price Target: $3.00
Current: $1.45
Upside: +107.61%
Aug 28, 2025
Maintained: Buy
Price Target: $26.50
Current: $13.25
Upside: +100.00%
Aug 8, 2025
Maintained: Buy
Price Target: $8.50
Current: $2.19
Upside: +288.13%
Mar 24, 2025
Maintained: Hold
Price Target: $1.00
Current: $0.60
Upside: n/a
Feb 27, 2025
Downgraded: Hold
Price Target: $5.95 → $7.40
Current: $2.36
Upside: n/a
Feb 21, 2023
Maintained: Hold
Price Target: $0.71 → $0.55
Current: $0.40
Upside: n/a
Sep 2, 2022
Downgraded: Hold
Price Target: $0.17 → $0.06
Current: $0.59
Upside: n/a
Aug 29, 2022
Maintained: Hold
Price Target: $0.50 → $0.55
Current: $0.115
Upside: n/a
Jun 1, 2022
Maintained: Buy
Price Target: $0.75
Current: $0.013
Upside: n/a